In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Ulcerative colitis
Rgs14 protein can worsen the severity
- Mastocytosis
Innovative pathogenesis-based therapeutic approaches in the pipeline
- Psychooncology
Communication as the key to therapy adherence
- Participation of the patient
Adherence in psychiatry
- From symptom to diagnosis
Renal cell carcinoma
- Lipid management: ESC/EAS guideline update 2025
New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH
- Chronically active MS lesions
New paradigm in the diagnosis and treatment of multiple sclerosis
- AI in neurology